Market Overview
According to the MarkNtel Advisors’ research report, “Global Tissue Imaging Market Analysis, 2021”, the market is likely to grow at a CAGR of around 8.96% during 2021-26 due to factors like the increasing identification of the early detection of diseases & diagnosis and growth of chronic disease cases. Alongside that, extensive investments by businesses across the globe in the healthcare sector and advanced technologies like AI & machine learning algorithms due to their efficiency in the early detection of diseases and their treatment are other prominent factors contributing to the market growth.
Impact of COVID-19
The outbreak of the Covid-19 pandemic had the most significant impact on the market and brought extensive challenges, especially in the pharmaceutical industry globally. It is now challenging for industries to return to their optimum pace, especially in developing countries across different regions. Further, the impact of the pandemic reduced the overall trade and imports, leading to a significant downfall in the market. However, with the gradual lifting of restrictions by governments, the market growth is likely to regain its pace in the forecast period.

Market Segmentation
Digital Pathology To Fuel The Market Share
Based on technology type, Digital Pathology is likely to fuel market growth in the coming years. The key factors leading to the rise include high-tech contributors with their predominant preference for synergistic activities like collaborations to sustain the enforcement globally and improve dominance. Hence, the global tissue imaging market is likely to witness substantial growth in the forecast years, reveals MarkNtel Advisors in their research report, "Global Tissue Imaging Market Analysis, 2021."
Hospitals & Diagnostic Laboratories To Possess Largest Market Share
Based on End-User Industries, Hospitals & Diagnostic Laboratories are likely to possess the largest market share in the forecast period due to the increasing cases of people with chronic diseases that need tools for tissue imaging and the integration of digital technology in tissue imaging. Moreover, a gradual shift towards better infrastructure of hospitals, operation rooms, and healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.
Regional Landscape
Asia-Pacific Attains The Fastest Growth
Asia-Pacific region is likely to attain the fastest growth in the global tissue imaging market. Several factors contributing to the rapid rise of demand and supply requirements in the APAC region are the rising incidents of chronic diseases & contagious conditions in patients, the growing biotechnology & pharmaceutical industries, and surging activities, including R&D in imaging procedures in the APAC.
Market Driver
Although the COVID-19 pandemic led to a significant downfall of the market, however, Global Tissue Imaging Market is likely to regain its speed in the forecast period. The factors that shall boost the market growth are the growing cases of people with chronic diseases & disorders that require tissue imaging and Digital Technology. Furthermore, a shift towards value-oriented healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.
Competitive Landscape
According to MarkNtel Advisors, the major leading players in the Global Tissue Imaging Market are Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others.
Key questions answered in the study
1. What are the current and future trends in the Global Tissue Imaging Market?
2. How has the industry been evolving in terms of geography and services adoption?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Global Tissue Imaging Market?
5. What are the customer orientation, purchase behavior, and expectations from the Global Tissue Imaging Market service providers across various regions?
Market Outlook, Segmentation, and Statistics
1) Impact of COVID-19 on the Global Tissue Imaging Market
2) Market Size & Analysis
a) By Revenue
3) Market Share & Analysis
a) By Technology
i) Mass Spectroscopy
(1) MALDI Imaging
(2) DESI Imaging
(3) SIMS Imaging
ii) Immunohistochemistry (IHC)
iii) Flow Cytometry
iv) Digital Pathology
v) In Situ Hybridization (ISH)
vi) Fluorescence In-Situ Hybridization (FISH)
(1) DNA Fluorescence In-Situ Hybridization
(2) RNA Fluorescence In-Situ Hybridization
(3) Protein Fluorescence In-Situ Hybridization
vii) Chromogenic In-Situ Hybridization (CISH)
viii) Immunofluorescence
(1) Indirect Immunofluorescence (Secondary)
(2) Direct Immunofluorescence (Primary)
b) By Product
i) Platforms
(1) Mass Spectroscopy Imaging (MSI) platforms
(2) Flow Cytometry Analyzers
(3) Digital Pathology Scanners
(4) Immunohistochemistry Detection Systems
(5) In-Situ Hybridization Platforms
(6) Immunofluorescence Imaging Analysis Systems
(7) Tissue Microarray Platforms
ii) Microscopes
(1) Optical Microscopes
(2) Compound Microscopes
(3) Digital Microscopes
(4) Fluorescence Microscopes
(5) Others
iii) Electron Microscopes
(1) Scanning Electron Microscopes (SEM)
(2) Transmission Electron Microscopes (TEM)
(3) Scanning Probe Microscopes
(4) Others
c) Consumables
i) Antibodies & Reagents
(1) Kits
(2) Probes
(3) Others
ii) Software
iii) Accessories
d) By Therapeutic Application
e) By Disease Research
i) Oncology Research
ii) Infectious Diseases Research
iii) Neurological Disease Research
iv) Cardiovascular Disease Research
v) Immunological Disease Research
vi) Other Diseases Research
f) By Diagnostics
i) Oncology Diagnostics
ii) Infectious Diseases Diagnostics
iii) Neurological Disease Diagnostics
iv) Cardiovascular Disease Diagnostics
v) Immunological Disease Diagnostics
vi) Other Diseases Diagnostics
g) By End User
i) Biotechnology Companies
ii) Pharmaceutical Companies
iii) Contract Research Organizations (CROs)
iv) Academic and Research Institutions
v) Hospitals and Diagnostic Laboratories
h) By Region
i) North America Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(1) The US Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(2) Canada Tissue Imaging Market Outlook, 2016-2026F (USD Million)
ii) South America Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(1) Brazil Tissue Imaging Market Outlook, 2016-2026F (USD Million)
iii) Europe Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(1) The UK Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(2) Germany Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(3) France Tissue Imaging Market Outlook, 2016-2026F (USD Million)
iv) Asia-Pacific Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(1) China Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(2) South Korea Tissue Imaging Market Outlook, 2016-2026F (USD Million)
(3) Japan Tissue Imaging Market Outlook, 2016-2026F (USD Million)
v) Middle East & Africa Tissue Imaging Market Outlook, 2016-2026F (USD Million)
i) By Competitors
i) Competition Characteristics
ii) Market Share & Analysis
iii) Competitive Metrix
j) The Global Tissue Imaging Market Hotspots & Opportunities
k) The Global Tissue Imaging Market Regulations & Policy
l) Key Strategic Imperatives for Success and Growth
m) Global Competition Outlook
i) Competition Matrix
ii) Company Profile